Kenneth J. Nicholson, CEO and President of FTAI Infrastructure Inc., filed a Form 4 on November 12, 2026, disclosing the open-market purchase of 400,000 shares of common stock on November 10, 2026.
Director David Morton Fox filed a Form 4 with the SEC on November 12, 2026, reporting the exercise of Series A Warrants in MediWound Ltd. (NASDAQ:MDWD) on November 10, 2026.
Sarah Oughtred, Chief Financial Officer of FIGS, Inc. (NYSE:FIGS), filed a Form 4 on November 12, 2026, disclosing the sale of 90,000 shares of Class A Common Stock on November 11, 2026.
Director Nachum Shamir filed a Form 4 with the SEC on November 12, 2026, reporting the exercise of Series A Warrants to acquire 16,336 ordinary shares of MediWound Ltd. (NASDAQ:MDWD) on November 10, 2026.
MediWound Ltd. Chief Executive Officer Ofer Gonen filed a Form 4 on November 12, 2026, disclosing the exercise of Series A Warrants to acquire 8,168 ordinary shares on November 10, 2026, at an exercise price of $13.475 per share.
Sally A. Washlow, Chief Executive Officer and Director of Orion Energy Systems, Inc., filed a Form 4 on November 12, 2026, disclosing an open-market purchase of common stock on November 11, 2026, along with previously reported derivative securities holdings.
Shabtai Adlersberg, President and CEO of AudioCodes Ltd, filed a Form 4 on November 12, 2026, disclosing three open-market purchases of ordinary shares made between November 9 and November 11, 2026.
David Chairman, SVP of R&D at Valens Semiconductor Ltd., filed a Form 4 on November 12, 2026, reporting the exercise of stock options and sale of ordinary shares on November 10 and November 11, 2026, pursuant to a Rule 10b5-1 trading plan.
Brian J. Caveney, EVP, President of BLS, CMO and CSO of Labcorp Holdings Inc., filed a Form 4 on November 12, 2026, disclosing a sale of common stock that occurred on November 10, 2026.
Steven L. Hoerter, Chairman, President and CEO of MBX Biosciences, Inc., filed a Form 4 on November 12, 2026, reporting the sale of 4,893 shares of common stock on November 10, 2026, to cover tax obligations arising from the vesting of restricted stock units.